Gensaic combines AI-powered protein design with unbiased directed evolution to develop tissue-selective ligands for targeted intracellular therapeutic delivery. 

The company's portfolio advances therapies for metabolic and age-related diseases, with an initial focus on siRNA payloads. FORGE™, Gensaic's proprietary product engine, integrates phage display for unbiased protein evolution within a generative AI architecture to discover and optimize protein molecules with enhanced tissue selectivity and drug-like properties. 

Founded through MIT and based in Cambridge, Massachusetts, Gensaic's team of physicians, bioengineers, and machine learning scientists is advancing a singular objective: to enable selective delivery of any therapeutic payload to any tissue of interest. 

For more information, please visit gensaic.com.

Gensaic

Lavi Erisson

Jonathan Hsu

Uyanga Tsedev

This department provides strategic direction and overall management for the organization.

Executive Leadership

This department focuses on advancing scientific knowledge and innovation through research and experimentation.

Gensaic

Org chart

Teams

Executive Leadership

Research and Development

Offices

Gensaic

Org chart

Teams

Executive Leadership

Research and Development

Offices

Related companies